Identification of a novel chalcone derivative that inhibits Notch signaling in T-cell acute lymphoblastic leukemia
Abstract Notch signaling is considered a rational target in the therapy of several cancers, particularly those harbouring Notch gain of function mutations, including T-cell acute lymphoblastic leukemia (T-ALL). Although currently available Notch-blocking agents are showing anti-tumor activity in pre...
Guardado en:
Autores principales: | Mattia Mori, Luca Tottone, Deborah Quaglio, Nadezda Zhdanovskaya, Cinzia Ingallina, Marisa Fusto, Francesca Ghirga, Giovanna Peruzzi, Maria Elisa Crestoni, Fabrizio Simeoni, Francesca Giulimondi, Claudio Talora, Bruno Botta, Isabella Screpanti, Rocco Palermo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d39668e761db46ddb4b089d4a0dbbce2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
NOTCH-ing up nucleotide metabolism in T-cell acute lymphoblastic leukemia
por: Andrew Volk
Publicado: (2021) -
Exploring the Assembly of Resorc[4]arenes for the Construction of Supramolecular Nano-Aggregates
por: Fabio Buonsenso, et al.
Publicado: (2021) -
Proteomics of resistance to Notch1 inhibition in acute lymphoblastic leukemia reveals targetable kinase signatures
por: Giulia Franciosa, et al.
Publicado: (2021) -
A conserved strategy of chalcone isomerase-like protein to rectify promiscuous chalcone synthase specificity
por: Toshiyuki Waki, et al.
Publicado: (2020) -
A threshold level of NFATc1 activity facilitates thymocyte differentiation and opposes notch-driven leukaemia development
por: Stefan Klein-Hessling, et al.
Publicado: (2016)